메뉴 건너뛰기




Volumn 28, Issue 1, 2008, Pages 1-7

Bioequivalence following buccal and sublingual placement of fentanyl buccal tablet 400 μg in healthy subjects

Author keywords

Bioequivalence; Drug delivery systems; Fentanyl, pharmacokinetics; Opioid analgesics, pharmacokinetics

Indexed keywords

FENTANYL; NALTREXONE; OPIATE;

EID: 37249044167     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200828010-00001     Document Type: Article
Times cited : (28)

References (14)
  • 2
    • 33645325108 scopus 로고    scopus 로고
    • Fentanyl effervescent buccal tablets: Enhanced buccal absorption
    • Durfee S, Messina J, Khankari R. Fentanyl effervescent buccal tablets: enhanced buccal absorption. Am J Drug Deliv 2006; (1): 1-5
    • (2006) Am J Drug Deliv , vol.1 , pp. 1-5
    • Durfee, S.1    Messina, J.2    Khankari, R.3
  • 4
    • 0032899247 scopus 로고    scopus 로고
    • Breakthrough pain: Characteristics and impact in patients with cancer pain
    • May;
    • Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999 May; 81 (1-2): 129-34
    • (1999) Pain , vol.81 , Issue.1-2 , pp. 129-134
    • Portenoy, R.K.1    Payne, D.2    Jacobsen, P.3
  • 5
    • 34948821962 scopus 로고    scopus 로고
    • Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain: A double-blind, randomized, placebo-controlled study
    • Jul-Aug;
    • Slatkin NE, Xie F, Messina J, et al. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain: a double-blind, randomized, placebo-controlled study. J Support Oncol 2007 Jul-Aug; 5 (7): 327-34
    • (2007) J Support Oncol , vol.5 , Issue.7 , pp. 327-334
    • Slatkin, N.E.1    Xie, F.2    Messina, J.3
  • 6
    • 33750322229 scopus 로고    scopus 로고
    • A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
    • Nov-Dec;
    • Portenoy RK, Taylor D, Messina J, et al. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Clin J Pain 2006 Nov-Dec; 22 (9): 805-11
    • (2006) Clin J Pain , vol.22 , Issue.9 , pp. 805-811
    • Portenoy, R.K.1    Taylor, D.2    Messina, J.3
  • 7
    • 0031597891 scopus 로고    scopus 로고
    • Buccal mucosa as a route for systemic drug delivery: A review
    • Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci 1998; 1: 15-30
    • (1998) J Pharm Pharm Sci , vol.1 , pp. 15-30
    • Shojaei, A.H.1
  • 8
    • 29244454227 scopus 로고    scopus 로고
    • Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers
    • Darwish M, Tempero K, Kirby M, et al. Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers. Clin Pharmacokinet 2005; 44 (12): 1279-86
    • (2005) Clin Pharmacokinet , vol.44 , Issue.12 , pp. 1279-1286
    • Darwish, M.1    Tempero, K.2    Kirby, M.3
  • 9
    • 33745972464 scopus 로고    scopus 로고
    • Darwish M, Kirby M, Robertson Jr P, et al. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400 and 800 μg in healthy adult volunteers. Clin Ther 2006 May; 28 (5): 707-14
    • Darwish M, Kirby M, Robertson Jr P, et al. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400 and 800 μg in healthy adult volunteers. Clin Ther 2006 May; 28 (5): 707-14
  • 10
    • 33845766668 scopus 로고    scopus 로고
    • Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers
    • Jan;
    • Darwish M, Kirby M, Robertson Jr P, et al. Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers. J Clin Pharmacol 2007 Jan; 47 (1): 56-63
    • (2007) J Clin Pharmacol , vol.47 , Issue.1 , pp. 56-63
    • Darwish, M.1    Kirby, M.2    Robertson Jr, P.3
  • 11
    • 0000722192 scopus 로고
    • Noncompartmental analysis based on statistical moment theory
    • Gibaldi M, Perrier D, editors, 2nd ed. New York: Marcel Dekker Inc
    • Gibaldi M, Perrier D. Noncompartmental analysis based on statistical moment theory. In: Gibaldi M, Perrier D, editors. Pharmacokinetics. 2nd ed. New York: Marcel Dekker Inc., 1982: 409-17
    • (1982) Pharmacokinetics , pp. 409-417
    • Gibaldi, M.1    Perrier, D.2
  • 12
    • 33746799704 scopus 로고    scopus 로고
    • Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics
    • Darwish M, Kirby M, Robertson P, et al. Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics. Clin Pharmacokinet 2006; 45 (8): 843-50
    • (2006) Clin Pharmacokinet , vol.45 , Issue.8 , pp. 843-850
    • Darwish, M.1    Kirby, M.2    Robertson, P.3
  • 13
    • 34548605294 scopus 로고    scopus 로고
    • Effect of buccal dwell time on the pharmacokinetic profile of fentanyl buccal tablet
    • Sep;
    • Darwish M, Kirby M, Jiang JG. Effect of buccal dwell time on the pharmacokinetic profile of fentanyl buccal tablet. Expert Opin Pharmacother 2007 Sep; 8 (13): 2011-6
    • (2007) Expert Opin Pharmacother , vol.8 , Issue.13 , pp. 2011-2016
    • Darwish, M.1    Kirby, M.2    Jiang, J.G.3
  • 14
    • 33746849278 scopus 로고    scopus 로고
    • Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 μg versus oral transmucosal fentanyl citrate 1600 μg and dose proportionality of FEBT 270 to 1300 μg: A single-dose, randomized, open-label, three-period study in healthy adult volunteers
    • May;
    • Darwish M, Tempero K, Kirby M, et al. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 μg versus oral transmucosal fentanyl citrate 1600 μg and dose proportionality of FEBT 270 to 1300 μg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers. Clin Ther 2006 May; 28 (5): 715-24
    • (2006) Clin Ther , vol.28 , Issue.5 , pp. 715-724
    • Darwish, M.1    Tempero, K.2    Kirby, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.